Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nu Holdings
NU
5
Liberty Latin America-A
LILA
CN Stock MarketDetailed Quotes
300267 Hunan Er-kang Pharmaceutical
- 3.12
- +0.52+20.00%
Market Closed Apr 24 15:00 CST
6.44BMarket Cap-18.46P/E (TTM)
3.12High2.60Low1.29MlotVolume2.60Open2.60Pre Close380.79MTurnover9.08%Turnover RatioLossP/E (Static)2.06BShares3.8852wk High1.44P/B4.44BFloat Cap2.0352wk Low3.12Limit Up1.42BShs Float23.06Historical High2.08Limit Down20.00%Amplitude1.20Historical Low--Dividend TTM2.95Avg Price671.20KlotAsk--Div YieldTTM100Lot Size573.71KlotBid
Hunan Er-kang Pharmaceutical Key Stats
EPS
According to the latest financial report of Hunan Er-kang Pharmaceutical, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Hunan Er-kang Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 2.16.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hunan Er-kang Pharmaceutical shows that the company's current ratio is 2.71, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hunan Er-kang Pharmaceutical, the quick ratio is 1.63, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Hunan Er-kang Pharmaceutical? The latest ROE figure is 0.63%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hunan Er-kang Pharmaceutical, the total asset return on investment (ROA) is 0.46%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hunan Er-kang Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 26.13%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hunan Er-kang Pharmaceutical, the net profit margin is 6.77%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs